These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 27635073)

  • 1. Clinical Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Adults With Congenital Heart Disease.
    Moore JP; Mondésert B; Lloyd MS; Cook SC; Zaidi AN; Pass RH; John AS; Fish FA; Shannon KM; Aboulhosn JA; Khairy P;
    Circ Arrhythm Electrophysiol; 2016 Sep; 9(9):. PubMed ID: 27635073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of implantable cardioverter-defibrillators in adult congenital heart disease patients: indications and outcomes.
    Santharam S; Hudsmith L; Thorne S; Clift P; Marshall H; De Bono J
    Europace; 2017 Mar; 19(3):407-413. PubMed ID: 27234868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-center experience with implantable cardioverter-defibrillators in adults with complex congenital heart disease.
    Khanna AD; Warnes CA; Phillips SD; Lin G; Brady PA
    Am J Cardiol; 2011 Sep; 108(5):729-34. PubMed ID: 21684513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implant and clinical characteristics for pediatric and congenital heart patients in the national cardiovascular data registry implantable cardioverter defibrillator registry.
    Jordan CP; Freedenberg V; Wang Y; Curtis JP; Gleva MJ; Berul CI
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1092-100. PubMed ID: 25287482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lesion-specific differences for implantable cardioverter defibrillator therapies in adults with congenital heart disease.
    Kella DK; Merchant FM; Veledar E; Book W; Lloyd MS
    Pacing Clin Electrophysiol; 2014 Nov; 37(11):1492-8. PubMed ID: 24889130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complications Associated With Implantable Cardioverter Defibrillators in Adults With Congenital Heart Disease or Left Ventricular Noncompaction Cardiomyopathy (From the NCDR
    Gleva MJ; Wang Y; Curtis JP; Berul CI; Huddleston CB; Poole JE
    Am J Cardiol; 2017 Nov; 120(10):1891-1898. PubMed ID: 28917495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular arrhythmias and sudden cardiac death in adults with congenital heart disease.
    Khairy P
    Heart; 2016 Nov; 102(21):1703-1709. PubMed ID: 27250216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Teenagers and Young Adults.
    Bettin M; Larbig R; Rath B; Fischer A; Frommeyer G; Reinke F; Köbe J; Eckardt L
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1499-1506. PubMed ID: 29759830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transvenous and non-transvenous implantable cardioverter-defibrillators in children, adolescents, and adults with congenital heart disease: who is at risk for appropriate and inappropriate shocks?
    Krause U; Müller MJ; Wilberg Y; Pietzka M; Backhoff D; Ruschewski W; Paul T
    Europace; 2019 Jan; 21(1):106-113. PubMed ID: 30339209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable cardioverter-defibrillator therapy to reduce sudden cardiac death in adults with congenital heart disease: A registry study.
    Slater TA; Cupido B; Parry H; Drozd M; Blackburn ME; Hares D; Pepper CB; Birkitt L; Cullington D; Witte KK; Oliver J; English KM; Sengupta A
    J Cardiovasc Electrophysiol; 2020 Aug; 31(8):2086-2092. PubMed ID: 32583559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defibrillators in adult congenital heart disease: Long-term risk of appropriate shocks, inappropriate shocks, and complications.
    Moore BM; Cao J; Cordina RL; McGuire MA; Celermajer DS
    Pacing Clin Electrophysiol; 2020 Jul; 43(7):746-753. PubMed ID: 32495949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter-defibrillators in adults with congenital heart disease: a systematic review and meta-analysis.
    Vehmeijer JT; Brouwer TF; Limpens J; Knops RE; Bouma BJ; Mulder BJ; de Groot JR
    Eur Heart J; 2016 May; 37(18):1439-48. PubMed ID: 26873095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous Implantable Cardioverter-Defibrillators in Patients With Congenital Heart Disease.
    Waldmann V; Marquié C; Bessière F; Perrot D; Anselme F; Badenco N; Barra S; Bertaux G; Blangy H; Bordachar P; Boveda S; Chauvin M; Clémenty N; Clerici G; Combes N; Defaye P; Deharo JC; Durand P; Duthoit G; Eschalier R; Fauchier L; Garcia R; Geoffroy O; Gitenay E; Gourraud JB; Guenancia C; Iserin L; Jacon P; Jesel-Morel L; Kerkouri F; Klug D; Koutbi L; Labombarda F; Ladouceur M; Laurent G; Leclercq C; Maille B; Maltret A; Massoulié G; Mondoly P; Ninni S; Ollitrault P; Pasquié JL; Pierre B; Pujadas P; Champ-Rigot L; Sacher F; Sadoul N; Schatz A; Winum P; Milliez PU; Probst V; Marijon E
    J Am Coll Cardiol; 2023 Aug; 82(7):590-599. PubMed ID: 37558371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific indications and clinical outcome in patients with subcutaneous implantable cardioverter-defibrillator (ICD) - A nationwide multicentre registry.
    Sponder M; Khazen C; Dichtl W; Fiedler L; Mörtl D; Teubl A; Steinwender C; Martinek M; Nürnberg M; Dalos D; Kastner J; Schukro C
    Eur J Intern Med; 2018 Feb; 48():64-68. PubMed ID: 28978409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes following the implantation of cardioverter-defibrillator for primary prevention in transposition of the great arteries after intra-atrial baffle repair: a single-centre experience.
    Buber J; Ackley TJ; Daniels CJ; Roble SL; Mah ML; Kamp AN; Kertesz NJ
    Europace; 2016 Jul; 18(7):1016-22. PubMed ID: 26705566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
    Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM
    Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of adult patients with congenital heart disease and an implantable cardioverter defibrillator.
    Coutinho Cruz M; Viveiros Monteiro A; Portugal G; Laranjo S; Lousinha A; Valente B; Osório P; Silva Cunha P; de Sousa L; Oliveira JA; Agapito A; Martins Oliveira M; Pinto F; Cruz Ferreira R
    Congenit Heart Dis; 2019 Jul; 14(4):525-533. PubMed ID: 30889316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
    Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten-year outcomes in adult patients with congenital heart disease and implantable cardioverter-defibrillators.
    Brouillard AM; Al-Hammadi N; Hunt C; Barger P; Ludbrook P; Gleva MJ
    Int J Cardiol; 2020 Aug; 313():39-45. PubMed ID: 32160963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity and specificity of the subcutaneous implantable cardioverter defibrillator pre-implant screening tool.
    Zeb M; Curzen N; Allavatam V; Wilson D; Yue A; Roberts P; Morgan J
    Int J Cardiol; 2015 Sep; 195():205-9. PubMed ID: 26048376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.